AWS Health Innovation Podcast podcast

#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio

0:00
27:30
Retroceder 15 segundos
Avanzar 15 segundos
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.

Otros episodios de "AWS Health Innovation Podcast"